SMTL ID : 7k8z.1

Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
hetero-3-2-2-mer
Ligands
13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Barnes, C.O. et al., SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature (2020)
Release Date
2020-10-21
Peptides
Spike glycoprotein: ABC
C135 Fab Heavy Chain: DF
C135 Fab Light Chain: EG
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
H
F
M
E
L
G
N

Spike glycoprotein

C135 Fab Heavy Chain

C135 Fab Light Chain

Toggle Identical (EG)

Related Entries With Identical Sequence

6xcm.1 | 6xcn.1 | 7k8r.1 | 7k8u.1 | 7k8v.1 | 7k8w.1